Innovative Study Identifies New Biomarkers for Lung Cancer Diagnostics Using Liquid Biopsy Technology

Introduction



In a groundbreaking double-blind study, Creatv Bio, a division of Creatv MicroTech, Inc., has explored the role of circulating cancer-associated macrophage-like cells (CAMLs) and epithelial-mesenchymal transition circulating tumor cells (EMT CTCs) as diagnostic tools for assessing indeterminate lung nodules. The research was conducted in collaboration with the renowned Fox Chase Cancer Center and the University of Pennsylvania, focusing on a population of patients with undetermined pulmonary nodules—which can often signal the presence of malignancies but are not always easy to diagnose.

Study Overview



The study, published in the Journal of Clinical Oncology – Precision Oncology in July 2026 (reference: 10e2501142), enrolled 203 patients with nodules measuring between 0.8 and 3.0 cm, all of whom had no prior diagnosis of cancer. Researchers aimed to evaluate whether the detection of CAMLs and EMT CTCs in blood samples could help ascertain malignancy in these patients.

Key Findings



The results showed that CAMLs were identified in 45% of the patient samples evaluated, while EMT CTCs were detected in 20% of cases. Notably, the positive predictive value (PPV) for CAMLs in indicating malignancy was recorded at 27.9%, while the negative predictive value (NPV) stood at 61.9%. The study also reported a sensitivity of 37.5% and a specificity of 51.2% for detecting any malignancy. Although CAMLs and EMT CTCs alone were not enough to clearly distinguish between benign and malignant cases, their presence together significantly improved specificity to 90.6%. This remarkable finding suggests that when both biomarkers are detected, they provide a stronger indication of malignancy status compared to either biomarker alone.

Understanding CAMLs and EMT CTCs



CAMLs are large, myeloid polyploid cells (greater than 50 microns) that circulate in the blood of patients with various cancers, even at the early stages of the disease. Their detection could thus potentially enable earlier diagnosis and intervention. EMT CTCs, on the other hand, are tumor cells that also circulate in the bloodstream and have been associated with cancer progression and therapeutic response. The study's findings underscore the importance of these biomarkers in monitoring the advancement of cancer and the effectiveness of subsequent treatments.

Significance of the Study



The implications of this research are profound, as it introduces a novel approach towards the diagnosis of lung cancer—particularly in cases where traditional imaging methods yield ambiguous results. The ability to use biomarkers to distinguish between types of nodules can enhance treatment pathways tailored to individual patients and potentially improve outcomes.

About Creatv Bio



Creatv Bio operates a CLIA-certified laboratory specializing in cancer diagnostics. Their work, particularly in developing liquid biopsy techniques, positions them at the forefront of cancer research and innovation. The liquid biopsy tests provided by Creatv are analytically validated for research and development purposes but are not yet designated for clinical diagnoses or disease monitoring in current practice. Interested parties can contact the team for detailed technical presentations and additional insights regarding CAML and EMT CTC biomarkers.

Conclusion



As research advances, the integration of biomarkers like CAMLs and EMT CTCs into clinical practice may revolutionize how indeterminate lung nodules are approached in the medical community. With further studies and validations, these findings could lead to a new era in cancer diagnostics, enhancing the accuracy and efficiency of cancer identification and treatment strategies.

For inquiries, please reach out directly to the Chief Scientific Officer or Business Officer at Creatv Bio.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.